JP2002520282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002520282A5 JP2002520282A5 JP2000558815A JP2000558815A JP2002520282A5 JP 2002520282 A5 JP2002520282 A5 JP 2002520282A5 JP 2000558815 A JP2000558815 A JP 2000558815A JP 2000558815 A JP2000558815 A JP 2000558815A JP 2002520282 A5 JP2002520282 A5 JP 2002520282A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hydrogen
- group
- lower alkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9246698P | 1998-07-09 | 1998-07-09 | |
| US60/092,466 | 1998-07-09 | ||
| US9487898P | 1998-07-29 | 1998-07-29 | |
| US60/094,878 | 1998-07-29 | ||
| PCT/US1999/015501 WO2000002555A1 (en) | 1998-07-09 | 1999-07-08 | Methods and compositions for the treatment of chronic lymphocytic leukemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002520282A JP2002520282A (ja) | 2002-07-09 |
| JP2002520282A5 true JP2002520282A5 (cg-RX-API-DMAC7.html) | 2006-10-05 |
Family
ID=26785713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000558815A Pending JP2002520282A (ja) | 1998-07-09 | 1999-07-08 | 慢性リンパ性白血病の処置のための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6573292B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1104297B8 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002520282A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE315392T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU767586B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2336932A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69929440T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1104297T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2255287T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ509376A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1104297E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000002555A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE315392T1 (de) * | 1998-07-09 | 2006-02-15 | Francis A Nardella | Zusammensetzungen zur behandlung chronischer lymphatischer leukämie |
| US7129262B2 (en) | 1999-07-23 | 2006-10-31 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
| US6545034B1 (en) | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
| US7151100B1 (en) | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
| US7361680B2 (en) | 1999-07-23 | 2008-04-22 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
| US7105560B1 (en) * | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
| US7211599B2 (en) | 2002-09-19 | 2007-05-01 | The Regents Of The University Of California | Use of etodolac to treat hyperplasia |
| JP2007507524A (ja) * | 2003-10-02 | 2007-03-29 | セフアロン・インコーポレーテツド | インドール誘導体 |
| US7638331B2 (en) | 2004-01-02 | 2009-12-29 | The Administration of the Tulane Rducation Fund | Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery |
| US20060128777A1 (en) * | 2004-11-05 | 2006-06-15 | Bendall Heather H | Cancer treatments |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
| EP2294186B1 (en) * | 2008-05-20 | 2019-10-09 | Incuron, Inc. | Inducing cell death by inhibiting adaptive heat shock response |
| JP5670335B2 (ja) | 2008-09-25 | 2015-02-18 | セファロン、インク． | ベンダムスチン液体製剤 |
| MX2011007557A (es) * | 2009-01-15 | 2011-08-12 | Cephalon Inc | Formas nuevas de bendamustina como base libre. |
| EP3246026A3 (en) | 2010-08-18 | 2018-02-21 | Del Mar Pharmaceuticals | Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol |
| WO2014081405A2 (en) | 2011-08-17 | 2014-05-30 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dibromodulcitol |
| US10201521B2 (en) | 2012-01-20 | 2019-02-12 | Del Mar Pharmaceuticals (Bc) Ltd. | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma |
| CA2868302A1 (en) | 2012-03-23 | 2013-09-26 | Dennis M. Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| US9814693B2 (en) | 2012-05-09 | 2017-11-14 | Delmar Pharmaceuticals, Inc. | Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies |
| BR112014032346A2 (pt) | 2012-06-26 | 2017-06-27 | Del Mar Pharmaceuticals | métodos para tratamento de malignidades resistentes ao inibidor de tirosina-quinase em pacientes com polimorfismos genéticos ou desregulações de ahi1 mutações empregando dianidrogalactitol, diacetildianidrogalactitol, dibromodulcitol, ou análogos ou derivados destes |
| KR102359214B1 (ko) | 2014-04-04 | 2022-02-07 | 델 마 파마슈티컬스 | 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체 |
| CN106572992A (zh) | 2014-04-06 | 2017-04-19 | 英丘伦有限责任公司 | 用curaxins进行组合治疗 |
| AU2017260706B2 (en) | 2016-05-04 | 2023-05-11 | Inmed Pharmaceuticals Inc. | Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders |
| WO2019056123A1 (en) | 2017-09-22 | 2019-03-28 | Inmed Pharmaceuticals Inc. | TOPICAL FORMULATIONS OF CANNABINOIDS AND THEIR USE IN THE TREATMENT OF PAIN |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL107185C (cg-RX-API-DMAC7.html) | 1957-12-19 | |||
| US3843480A (en) | 1963-08-28 | 1974-10-22 | D Dreher | Dry dry transfer |
| US3948262A (en) | 1969-04-01 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
| US3993073A (en) | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US3974179A (en) | 1971-06-01 | 1976-08-10 | American Home Products Corporation | 1,3,4,9-Tetrahydropyrano[3,4-b]indole-1-acetamides and derivatives |
| US3939178A (en) | 1971-06-01 | 1976-02-17 | American Home Products Corporation | Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles |
| US3843681A (en) | 1971-06-01 | 1974-10-22 | American Home Prod | 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives |
| US3948254A (en) | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
| US3839178A (en) * | 1972-10-05 | 1974-10-01 | Gen Electric | Potentiometric oxygen sensor |
| US4310509A (en) | 1979-07-31 | 1982-01-12 | Minnesota Mining And Manufacturing Company | Pressure-sensitive adhesive having a broad spectrum antimicrobial therein |
| US4291015A (en) | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| JPS5777617A (en) | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
| IL61721A (en) | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
| US4542013A (en) | 1981-07-08 | 1985-09-17 | Key Pharmaceuticals, Inc. | Trinitroglycerol sustained release vehicles and preparation therefrom |
| US4460562A (en) | 1982-01-06 | 1984-07-17 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing propranolol |
| US4485097A (en) | 1982-05-26 | 1984-11-27 | Massachusetts Institute Of Technology | Bone-equivalent and method for preparation thereof |
| US4542012A (en) | 1982-07-02 | 1985-09-17 | Minnesota Mining And Manufacturing Company | Film-forming composition containing an antimicrobial agent and methods |
| US4608249A (en) | 1982-11-02 | 1986-08-26 | Nitto Electric Industrial Co., Ltd. | Hydrophilic therapeutic material |
| IT1153909B (it) | 1982-12-17 | 1987-01-21 | Sogimi Srl | Polimeri reattivi per la cura di affezioni cutanee |
| GB8317576D0 (en) | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
| US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
| US4585877A (en) | 1985-05-06 | 1986-04-29 | American Home Products Corporation | Process for preparing 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)-indole-1-acetic acid, etodolac |
| GB8514665D0 (en) | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
| US4748252A (en) | 1986-08-15 | 1988-05-31 | American Home Products Corporation | Substituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acids |
| US4686213A (en) * | 1986-08-15 | 1987-08-11 | American Home Products Corporation | Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids |
| DE69328838T2 (de) | 1992-03-13 | 2000-10-12 | Sepracor Inc., Marlborough | Antipyretische und analgetische verfahren und zusammensetzungen, die optisch reines r-etodolac enthalten |
| US5955504A (en) | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
| US6160018A (en) | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
| US5981592A (en) * | 1995-03-13 | 1999-11-09 | Loma Linda University Medical Center | Method and composition for treating cystic fibrosis |
| US5599946A (en) | 1995-05-30 | 1997-02-04 | Teva Pharmaceutical Industries Ltd. | 3-(2-trialkylsilyloxy)ethyl-7-ethyl-1H-indoles and method for their preparation |
| US5968974A (en) | 1995-07-19 | 1999-10-19 | Merck & Co., Inc. | Method of treating colonic adenomas |
| NZ312997A (en) * | 1995-07-19 | 2000-07-28 | Merck & Co Inc | use of a non-steroidal anti-inflammatory agent for treating colonic adenomas |
| US6255347B1 (en) | 1996-06-21 | 2001-07-03 | Advanced Research And Technology Institute | Methods and compositions comprising R-ibuprofen |
| WO1998004527A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Pyranoindole and carbazole inhibitors of cox-2 |
| US5776967A (en) | 1996-07-26 | 1998-07-07 | American Home Products Corporation | Pyranoindole inhibitors of COX--2 |
| PT1586322E (pt) * | 1996-11-05 | 2008-10-27 | Childrens Medical Center | Composições que compreendem talidomida e dexametasona para o tratamento de cancro |
| US5939455A (en) * | 1997-03-11 | 1999-08-17 | Beacon Laboratories, Inc. | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
| ATE315392T1 (de) * | 1998-07-09 | 2006-02-15 | Francis A Nardella | Zusammensetzungen zur behandlung chronischer lymphatischer leukämie |
| US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
| US6545034B1 (en) * | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
| WO2002012188A2 (en) | 2000-08-09 | 2002-02-14 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
-
1999
- 1999-07-08 AT AT99937222T patent/ATE315392T1/de not_active IP Right Cessation
- 1999-07-08 ES ES99937222T patent/ES2255287T3/es not_active Expired - Lifetime
- 1999-07-08 JP JP2000558815A patent/JP2002520282A/ja active Pending
- 1999-07-08 NZ NZ509376A patent/NZ509376A/en unknown
- 1999-07-08 US US09/720,992 patent/US6573292B1/en not_active Expired - Fee Related
- 1999-07-08 WO PCT/US1999/015501 patent/WO2000002555A1/en not_active Ceased
- 1999-07-08 DE DE69929440T patent/DE69929440T2/de not_active Expired - Fee Related
- 1999-07-08 DK DK99937222T patent/DK1104297T3/da active
- 1999-07-08 EP EP99937222A patent/EP1104297B8/en not_active Expired - Lifetime
- 1999-07-08 CA CA002336932A patent/CA2336932A1/en not_active Abandoned
- 1999-07-08 AU AU52098/99A patent/AU767586B2/en not_active Ceased
- 1999-07-08 PT PT99937222T patent/PT1104297E/pt unknown
-
2003
- 2003-03-31 US US10/404,943 patent/US6921772B2/en not_active Expired - Fee Related
-
2005
- 2005-07-26 US US11/190,356 patent/US20050261356A1/en not_active Abandoned